Home Tags Antibiotic Resistance
Antibiotic Resistance Related Content
Professor Sandra Carvalho, University of Minho, Department of Physics, discusses the emergence of surface functionalization as a strategy in biotech and health.
Here, Professor Gerald Misinzo and Professor Mark Rweyemamu discuss the potential of the RSIF-PASET Programme.
Josep Figueras and Anna Sagan from the European Observatory on Health Systems and Policies focus here on antimicrobial resistance and ponder whether or not this could be the next big pandemic.
Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.
The University of Plymouth revealed that secondary COVID-19 treatment could be increasing antibiotic resistance and polluting water.
Well-managed and healthy livestock play a key role in the European Green Deal, Roxane Feller, Secretary General of AnimalhealthEurope argues.
Researchers say that the use of drugs to create glowing bacteria could decrease the need for prescribing antibiotics.
Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.
Daniel Berman, Head of Global Health, Nesta Challenges, says that it should not have taken COVID-19 to emphasise the necessity of rapid testing.
Writer Megan Warrender looks at strengthening research and innovation in strategically important areas such as automation, antibiotic resistance and quantum technology.
Nina Lindfors, Director of Teaching and Research at Helsinki University Hospital, illuminates us about a new approach to infection treatment that concerns an antibacterial bioactive glass for bone reconstruction.
Peter Jackson, Executive Director of the AMR Centre, describes new initiatives and partnerships that point the way forward for the UK’s antimicrobial resistance response.
Daniel Berman, Head of Global Health, Nesta Challenges, highlights the need for radical change in how innovation is funded and prioritised to ensure an antibiotic future given AMR is still climbing, even though behaviours are changing.
Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.
Only 11% of Brits see antimicrobial resistance as a serious threat to society, despite the outgoing UK Chief Medical Officer saying earlier this year that Superbugs “could kill us before climate change does”.
The Keep Antibiotics Working campaign is back to alert the public to the risks of antibiotic resistance, urging people to always take their doctor, pharmacist or nurse’s advice.
Resistance to antibiotics used for treating harmful bacteria related to a variety of stomach conditions has more than doubled in 20 years, new research presented at UEG Week Barcelona 2019 has shown.
Paula Gomes, Associate Professor of Chemistry and Senior Researcher in Bioorganic and Peptide Chemistry at the University of Porto, Portugal, explains why peptides are amongst the most promising molecules for the future.
The EU-funded project FLEXPOL (GA number 721062) offers an affordable approach to prohibit the spread of bacteria and healthcare-associated infections using cost-effective and sustainable film products.
The priorities of Vytenis Andriukaitis, the current European Commissioner for Health & Food Safety are explained here.